BlackRock Fund Advisors - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 88 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2016$18,275,000
+39.5%
1,493,076
+34.4%
0.00%0.0%
Q3 2016$13,104,000
+43.8%
1,110,548
+6.0%
0.00%
+50.0%
Q2 2016$9,114,000
+58.1%
1,047,584
-4.2%
0.00%
+100.0%
Q1 2016$5,765,000
-42.7%
1,093,928
-15.6%
0.00%
-50.0%
Q4 2015$10,056,000
+3.3%
1,295,900
+4.8%
0.00%
-33.3%
Q3 2015$9,734,000
-18.1%
1,236,835
-5.7%
0.00%0.0%
Q2 2015$11,879,000
-30.9%
1,311,201
-0.9%
0.00%
-25.0%
Q1 2015$17,179,000
+8.9%
1,323,517
+14.1%
0.00%0.0%
Q4 2014$15,781,000
+74.6%
1,159,521
+15.1%
0.00%
+33.3%
Q3 2014$9,040,000
-35.4%
1,007,817
-2.5%
0.00%
-25.0%
Q2 2014$13,984,000
+39.4%
1,033,525
+2.4%
0.00%
+33.3%
Q1 2014$10,030,000
-22.5%
1,009,065
+3.6%
0.00%
-25.0%
Q4 2013$12,943,000
+5.1%
973,906
-4.0%
0.00%0.0%
Q3 2013$12,319,000
+62.9%
1,014,749
+38.9%
0.00%
+33.3%
Q2 2013$7,561,000730,7010.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders